Sort
15,273 grants matching “antimicrobial resistance”
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
$623,681Lars Eckmann · University Of California, San Diego · R01 · FY2017 · AI
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
$623,681Lars Eckmann · University Of California, San Diego · R01 · FY2019 · AI
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
$623,681Lars Eckmann · University Of California, San Diego · R01 · FY2016 · AI
BIOCHEMISTRY OF BACTERIAL CELL MEMBRANES
$623,543University Of California Berkeley · R01 · FY2004 · AI
A Total Infection Control Foley Catheter System
$623,143Shantha Sarangapani · Innovative Chemical/Environmental Tech · R44 · FY2007 · DK
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
$623,075Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2010 · AI
In vivo Core
$622,999David R Andes · University Of Wisconsin-Madison · U19 · FY2019 · AI
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$622,838Marco Colonna · Washington University · R01 · FY2023 · DK
Prevention of Cerebrospinal Fluid (CSF) Shunt Infections
$622,802Tamara Danielle Simon · Seattle Children'S Hospital · R01 · FY2019 · NS
Synthetic and translational studies of antitumor and antimicrobial natural products.
$622,230Seth B. Herzon · Yale University · R35 · FY2024 · GM
Synthetic and translational studies of antitumor and antimicrobial natural products.
$622,230Seth B. Herzon · Yale University · R35 · FY2025 · GM
Chemistry Core
$622,210Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2021 · AI
Bacterial manipulation of atypical ubiquitin signaling
$622,130Jonathan N Pruneda · Oregon Health & Science University · R01 · FY2025 · AI
Genomics-Assisted Antibiotic Discovery from Unprecedented Microbes of the Great Salt Lake
$622,123Jaclyn Marie Winter · University Of Utah · R01 · FY2022 · AI
Determinants of H. influenzae Virulence in Otitis Media
$622,078Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · DC
Transcription Termination and its Regulation in E. coli
$622,046Evgeny Nudler · New York University School Of Medicine · R01 · FY2010 · GM
Risk factors for drug resistant pneumococcal bacteremia
$621,971University Of Pennsylvania · R01 · FY2005 · AI
Rapid AST through Metabolic Imaging at Single Cell Level
$621,858Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2024 · AI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii
$621,666Mario Feldman · Washington University · R01 · FY2019 · AI
Antimicrobial discovery from metabolomics of nematode pathogen interactions
$621,659Dennis H Kim · Massachusetts Institute Of Technology · R01 · FY2016 · AT
In vitro core
$621,584F. Michael Hoffmann · University Of Wisconsin-Madison · U19 · FY2023 · AI
Discovery, Structural Studies and Biosynthesis of Biologically Active Natural Products and Natural Product-Like Inhibitors
$621,127Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): POPULATION PHARMACOKINETICS STUDY
$621,114Emmanuel B Walter · Duke University · N01 · FY2017 · AI
Anti-infectives that target bacterial ribosomes
$621,051Wayne State University · U01 · FY2004 · AI
CAREER: Targeting therapeutic liposomes to fungal infections
$620,826Anita Shukla · Brown University · · FY2020 · ENG